drugset / Trial / NCT01108926

PK of Tenofovir, Emtricitabine and Efavirenz in Healthy Volunteers

NCT01108926

Phase 1 Completed 19 enrolled St Stephens Aids Trust
NaSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to look at the levels of three HIV medications: tenofovir, emtricitabine, and efavirenz in blood after the drug intake has been stopped in order to understand how long these drugs persist in the blood. The study will specifically look at blood levels of these three drugs (taken as a 3-in-1 tablet) after taking them every day for 14 days. This study is not randomised which means that all subjects will receive all study medications in the same order. You and the study doctor will know which study medications you are taking at all times during the study.

Timeline

Start
2010-06
Primary completion
2010-10
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Efavirenz Other / unclassified 600 mg Oral
Subject Tenofovir Small molecule 245 mg Oral
Subject emtricitabine Other / unclassified 200 mg Oral